Nathalie Cozic

Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial

Denis Moro‐Sibilot, Nathalie Cozic, M. Pérol et al. · Annals of Oncology · 2019 · 192 citations · Full text

Medicinal Chemistry, Ros1-positive Nsclc, Medicine +4

High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008

Uta Dirksen, Bernadette Brennan, Marie‐Cécile Le Deley et al. · Journal of Clinical Oncology · 2019 · 136 citations · Full text

Early High-Volume Hemofiltration versus Standard Care for Post–Cardiac Surgery Shock. The HEROICS Study

Alain Combes, Nicolas Bréchot, Julien Amour et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 117 citations

1215O - SC Neoadjuvant atezolizumab (A) for resectable non-small cell lung cancer (NSCLC): Results from the phase II PRINCEPS trial

Benjamin Besse, Julien Adam, Nathalie Cozic et al. · Annals of Oncology · 2020 · 88 citations

A randomized, controlled, double-blind, crossover trial of zonisamide in myoclonus-dystonia

Élodie Hainque, Marie Vidailhet, Nathalie Cozic et al. · Neurology · 2016 · 75 citations